Citations

Showing 10 of 108083 citations.

Introducing Machine Perfusion into Routine Clinical Practice for Liver Transplantation in the United States: The Moment Has Finally Come
Croome, Kristopher P. , Croome, Kris P

Mayo Clinic

Journal of Clinical Medicine | January 24, 2023 | Volume: 12 | Issue: 3 | Pages: 909

10.3390/jcm12030909 | PMID 36769557 Get It

While adoption of machine perfusion technologies into clinical practice in the United States has been much slower than in Europe, recent changes in the transplant landscape as well as device availability following FDA approval have paved the way for rapid growth. Machine perfusion may provide one mechanism to maximize the utilization of potential donor liver grafts. Indeed, multiple studies have shown increased organ utilization with the implementation of technologies such as ex-situ normothermic machine perfusion (NMP), ex-situ hypothermic machine perfusion (HMP) and in-situ normothermic regional perfusion (NRP). The current review describes the history and development of machine perfusion utilization in the Unites States along with future directions. It also describes the differences in landscape between Europe and the United States and how this has shaped clinical application of these technologies.
An atlas of the bone marrow bone proteome in patients with dysproteinemias.
Dasari, Surendra , Drake, Matthew T. , Charlesworth, M. Cristine , Johnson, Kenneth L. , Pujari, Ganesh, Jevremović, Dragan , Kourelis, Taxiarchis , Ho, Matthew , Visram, Alissa , Drake, Matthew T , Charlesworth, Cristine, Johnson, Kenneth , Jevremovic, Dragan , Kourelis, Taxiarchis , Ho, Matthew

Mayo Clinic

No container title available | January 23, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2468383/v1 | PMID 36747663 Get It

Abstract Multiple myeloma (MM) bone disease is a significant cause of morbidity but there is a paucity of data on the impact of malignant plasma cells on adjacent trabecular bone within the BM. Here, we characterize the proteome of trabecular bone tissue from BM biopsies of 56 patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering (SMM), newly diagnosed (NDMM), relapsed MM (RMM), and normal controls. Proteins involved in extracellular matrix (ECM) formation and immunity pathways were decreased in SMM and active MM. Among the proteins most decreased were immunoglobulins, type IV collagen, and TIMP3, suggesting increased immunoparesis and decreased ECM remodelling within trabecular bone. Proteins most increased in SMM/MM were APP (enhances osteoclast activity), ENPP1 (enhances bone mineralization), and MZB1 (required for normal plasmablast differentiation). Pathway analyses showed that proteins involved in gamma -carboxylation, a pathway implicated in osteocalcin function, osteoblast differentiation, and normal hematopoiesis, were also overexpressed in SMM/MM. This study is the first comprehensive proteomic atlas of the BM bone proteome in dysproteinemias. We identify new key proteins and pathways for MM bone disease and potentially impaired hematopoiesis, and show for the first time that gamma -carboxylation pathways are increased in the bone tissue of SMM/MM.
Outcomes of Primary Simultaneous Pancreas-kidney Transplants by Induction Agent in the United States
Cerise, Adam , Shaker, Tamer , LeNguyen, Phuoc, Ramanathan, Karthik, Humphreville, Vanessa , Kandaswamy, Raja , Dinesh, Anant , Ramanathan, Karthik V. , Jackson, Scott , Riad, Samy

Mayo Clinic

Transplantation Direct | January 23, 2023 | Volume: 8 | Issue: 12 | Pages: e1412

10.1097/txd.0000000000001412 | PMID 36406900 Get It

Background. Long-term outcome data by induction type in simultaneous pancreas-kidney (SPK) is limited. Methods. Utilizing the Scientific Registry of Transplant Recipients, we examined all primary SPK transplants between 2000 and 2020, excluding crossmatch-positive recipients. We grouped recipients according to induction regimen into 3 groups: rabbit anti-thymocyte globulin (r-ATG) (n = 5678), alemtuzumab (n = 1199), and interleukin-2 receptor antagonist (IL-2RA; n = 1593). We analyzed the 10-y recipient and composite (kidney and pancreas) graft survival using the Kaplan-Meier survival function. Cox-proportion hazard models were generated to examine the association between induction type, the 10-y recipient, and graft survival. Models were adjusted for recipient age, sex, ethnicity, HLA-mismatch, diabetes type, dialysis dependency, cold-ischemia time, local versus imported organs, panel reactive antibody, steroid maintenance, and Pancreas Donor Risk Index. Results. r-ATG was associated with the lowest 1-y kidney and pancreas rejection rates compared with other agents (P < 0.001). In the univariable analysis, induction type was not associated with recipient (log-rank P = 0.11) or graft survival (log-rank P = 0.36). In the multivariable model for the composite graft survival, alemtuzumab use was associated with 22% increased kidney or pancreas graft loss compared with r-ATG (adjusted hazard ratio, 1.22; 95% confidence interval, 1.05–1.42), whereas IL-2RA use was not a predictor of graft survival. Induction type did not influence recipient survival in the adjusted model. Conclusions. r-ATG use was associated with the lowest SPK rejection rates. Compared with r-ATG, alemtuzumab but not IL-2RA was associated with worse long-term death-censored SPK graft outcome. Our analysis supports the common use of r-ATG for induction in US primary SPK recipients.
No patient left behind: A multilayered approach to mitigate COVID‐19 in transplant recipients
Yetmar, Zachary A. , Razonable, Raymund R.

Mayo Clinic

Transplant Infectious Disease | January 23, 2023 | Volume: 25 | Issue: 1 | Pages: No page available

10.1111/tid.13956 | PMID 36689293 Get It

Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
Fu, Zhuxuan , Irvin, Sarah , Anton‐Culver, Hoda , Beckmann, Matthias W. , Chang‐Claude, Jenny, Cook, Linda , Cushing‐Haugen, Kara L. , Fasching, Peter A. , Gayther, Simon A. , Giles, Graham G. , Goode, Ellen L. , Kaaks, Rudolf , Kotsopoulos, Joanne , Le, Nhu D. , Matsuo, Keitaro , McGuire, Valerie, McLaughlin, John R, Menon, Usha , Moysich, Kirsten B. , Pearce, Celeste Leigh , Pike, Malcolm C. , Ramus, Susan J. , Riggan, Marjorie J. , Rothstein, Joseph H. , Schildkraut, Joellen M. , Sieh, Weiva , Sutphen, Rebecca , Terry, Kathryn L. , Thompson, Pamela J., Titus, Linda , Altena, Anne M. van , White, Emily, Whittemore, Alice S. , Wu, Anna H. , Wentzensen, Nicolas , Group, AOCS, Risch, Harvey A. , Modugno, Francesmary , Zheng, Wei , Anton-Culver, Hoda , Giles, Graham G , Kaaks, Rudolf , Kotsopoulos, Joanne , Matsuo, Keitaro , Menon, Usha , Ramus, Susan J , Sieh, Weiva , van Altena, Anne M , Ziogas, Argyrios , Wentzensen, Nicolas , Risch, Harvey A , Modugno, Francesmary , Moysich, Kirsten , Zheng, Wei , Fu, Zhuxuan , Goodman, Marc T , Brooks, Maria M. , Jordan, Susan J. , Aben, Katja K.H. , Bandera, Elisa V. , Berchuck, Andrew , Brooks‐Wilson, Angela , Cook, Linda S, Cramer, Daniel W. , Doherty, Jennifer A. , Ekici, Arif B. , Fortner, Renée T. , Gentry‐Maharaj, Aleksandra , Goodman, Marc T. , Harris, Holly R. , Hein, Alexander , Kiemeney, Lambertus A. , Köbel, Martin , Lee, Alice W. , McLaughlin, John R, Milne, Roger L. , Qin, Bo , Zheng, Wei , Ziogas, Argyrios , Taylor, Sarah E , Tang, Lu , Songer, Thomas J. , Webb, Penelope M. , Group, AOCS

Mayo Clinic

JNCI: Journal of the National Cancer Institute | January 23, 2023 | Volume: 115 | Issue: 5 | Pages: 539-551

10.1093/jnci/djad011 | PMID 36688720 Get It

Abstract Background The role of ovulation in epithelial ovarian cancer (EOC) is supported by the consistent protective effects of parity and oral contraceptive use. Whether these factors protect through anovulation alone remains unclear. We explored the association between lifetime ovulatory years (LOY) and EOC. Methods LOY was calculated using 12 algorithms. Odds ratios (ORs) and 95% confidence intervals (CIs) estimated the association between LOY or LOY components and EOC among 26 204 control participants and 21 267 case patients from 25 studies. To assess whether LOY components act through ovulation suppression alone, we compared beta coefficients obtained from regression models with expected estimates assuming 1 year of ovulation suppression has the same effect regardless of source. Results LOY was associated with increased EOC risk (OR per year increase = 1.014, 95% CI = 1.009 to 1.020 to OR per year increase = 1.044, 95% CI = 1.041 to 1.048). Individual LOY components, except age at menarche, also associated with EOC. The estimated model coefficient for oral contraceptive use and pregnancies were 4.45 times and 12- to 15-fold greater than expected, respectively. LOY was associated with high-grade serous, low-grade serous, endometrioid, and clear cell histotypes (ORs per year increase = 1.054, 1.040, 1.065, and 1.098, respectively) but not mucinous tumors. Estimated coefficients of LOY components were close to expected estimates for high-grade serous but larger than expected for low-grade serous, endometrioid, and clear cell histotypes. Conclusions LOY is positively associated with nonmucinous EOC. Differences between estimated and expected model coefficients for LOY components suggest factors beyond ovulation underlie the associations between LOY components and EOC in general and for non-HGSOC.
Biological sex as a modulator in rhinologic anatomy, physiology, and pathology: A scoping review
Ramkumar, Shreya P. , Brar, Tripti , Marks, Lisa , Marino, Michael J. , Lal, Devyani , Lal, Devyani , Marks, Lisa A

Mayo Clinic

International Forum of Allergy & Rhinology | January 23, 2023 | Volume: 13 | Issue: 9 | Pages: 1783-1800

10.1002/alr.23135 | PMID 36688669 Get It

AbstractBackgroundBiological sex is increasingly recognized as a critical variable in health care. The authors reviewed the current literature regarding sex‐based differences in rhinology to summarize the data and identify critical knowledge gaps.MethodsA scoping review was conducted. Publications reporting sex‐based differences in anatomy, physiology, and pathology focusing on disease prevalence, disease burden, and outcomes in rhinology were identified.ResultsSeventy‐five relevant manuscripts were identified. While paranasal sinuses are of similar size at birth, they become larger in males leading to differences in ostium location. Females outperform males in olfactory identification but only in the 18‐ to 50‐year age group. Estrogen and progesterone administration can impact muscarinic and α1‐adrenergic nasal mucosa receptor density. Chronic rhinosinusitis (CRS) and CRS without nasal polyps are more prevalent in females while CRS with nasal polyps is more prevalent in males. CRS symptom burden is higher in females before and after endoscopic sinus surgery; however, no difference in endoscopic sinus surgery utilization was found based on sex. Allergic rhinitis is more common in males before puberty and in females after puberty. Epistaxis is more prevalent in males and postmenopausal females compared with premenopausal females, perhaps from differences in sex‐hormonal and hypertension status. In nasopharyngeal carcinoma, the incidence of sinus abnormalities was higher in males than females.ConclusionsAlthough many sex‐based differences exist in rhinology, further research is necessary to offer evidence‐based treatment guidelines. Gonadal hormones should be studied as a therapeutic in rhinologic pathology as baseline physiologic differences exist such as those found in nasal mucosa receptor density.
Transvenous embolization of cerebrospinal fluid-venous fistulas: Independent validation and feasibility of upper-extremity approach and using dual-microcatheter and balloon pressure cooker technique
Parizadeh, Donna , Fermo, Olga , Larco, Jorge Arturo , Quiñones‐Hinojosa, Alfredo , Clendenen, Steven R. , Rozen, Todd D. , Vibhute, Prasanna , Arturo Larco, Jorge L , Erben, Young M, Clendenen, Steven, Huynh, Thien J, Parizadeh, Donna , Gupta, Vivek , Grewal, Sanjeet S. , Erben, Young , Huynh, Thien

Mayo Clinic

Journal of NeuroInterventional Surgery | January 23, 2023 | Volume: 15 | Issue: 12 | Pages: 1234-1241

10.1136/jnis-2022-019946 | PMID 36690439 Get It

Background Transvenous embolization is emerging as a promising treatment for cerebrospinal fluid-venous fistulas (CVF) associated with spontaneous intracranial hypotension (SIH). Objective To perform an independent validation of the efficacy and safety of the procedure and describe the procedural techniques used at our institution. Methods A retrospective review was performed including consecutive patients with SIH who had undergone CVF embolization with 3-month clinical and imaging follow-up. Clinical evaluation included the Patient Global Impression of Change (PGIC) Scale and six-item Headache Impact Test (HIT-6). Bern SIH score was used for imaging evaluation on brain MRI. Post-treatment changes in scores were assessed by Wilcoxon signed rank test. Procedural technical details, including use of upper-extremity access and dual-microcatheter pressure cooker technique, were recorded. Results 18 patients (13 female, median age 60 years) were included. 17 (94%) procedures were performed with upper-extremity access and 12 (67%) using dual-microcatheter pressure cooker technique. After embolization, 16 (89%) patients reported much or very much improved at follow-up PGIC; median (IQR) HIT-6 score improved from 68 (62–72) to 36 (36–38) and Bern SIH score improved from 8 (6–8) to 3 (1.5–3.5), p values <0.001. Side effects were transient embolization site back pain in 15 (83%) and rebound intracranial hypertension requiring medical management in 9 (50%) patients. HIT-6 and Bern SIH score changes were similar between conventional and pressure cooker techniques ( p values >0.05). Conclusion Transvenous embolization is independently validated as a highly effective and safe treatment for CVF and is feasible using upper-extremity venous access. Dual-microcatheter and balloon/coil pressure cooker techniques may be used to optimize distribution of embolic material and potentially, treatment efficacy.
Isolated, Full-Thickness Proximal Rectus Femoris Injury in Competitive Athletes: A Systematic Review of Injury Characteristics and Return to Play
Knapik, Derrick M. , Alter, Thomas D. , Ganapathy, Aravinda , Smith, Matthew V. , Matava, Matthew J. , Brophy, Robert H.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | January 23, 2023 | Volume: 11 | Issue: 1 | Pages: No page available

10.1177/23259671221144984 | PMID 36743725 Get It

Background: Characteristics regarding mechanism of injury, management, and return-to-play (RTP) rate and timing are important when treating and counseling athletes with rectus femoris tears. Purpose: To systematically review the literature to better understand the prevalence, sporting activity, injury mechanisms, and treatment of patients with rectus femoris injury and to provide prognostic information regarding the rate and timing of RTP. Study Design: Systematic review; Level of evidence, 4. Methods: Following the 2020 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we queried PubMed/MEDLINE, Cochrane, OVID, EMBASE, and Google Scholar in March 2022 for studies reporting on athletes sustaining isolated, full-thickness tearing, or bony avulsion injuries to the proximal rectus femoris during sporting activity. Excluded were studies without evidence of full-thickness tearing or avulsion, with athletes sustaining concomitant injuries, or with injuries occurring from nonsporting activities. The percentage of athletes sustaining injuries was calculated based on sport, injury mechanism, and management (nonoperative versus operative). Results: Of 132 studies initially identified, 18 were included, comprising 132 athletes (mean age, 24.0 ± 5.4 years; range, 12-43 years). The most common sporting activities were soccer (70.5%) and rugby (15.2%). The most reported mechanisms of injury were kicking (47.6%) and excessive knee flexion/forced hip extension (42.9%). Avulsion injuries were reported in 86% (n = 114) of athletes. Nonoperative management was reported in 19.7% of athletes, with operative management performed in 80.3%. The mean follow-up time was 21.4 ± 11.4 months (range, 1.5-48 months). The RTP rate was 93.3% (n = 14) in nonoperatively treated and 100% (n = 106) in operatively treated athletes, and the mean RTP time was 11.7 weeks (range, 5.5-15.2 weeks) in nonoperatively treated and 22.1 weeks (range, 14.0-37.6 weeks) in operatively treated athletes. Complications were reported in 7.7% (2/26) of nonoperatively treated and 18% (n = 19/106) of operatively treated athletes. Conclusion: Full-thickness proximal rectus femoris injuries occurred most frequently in athletes participating in soccer and rugby secondary to explosive, eccentric contractions involved in kicking and sprinting. Operative management was performed in the majority of cases. Athletes who underwent operative repair had a 100% RTP rate versus 93.3% in athletes treated nonoperatively.
Fetal surgery is not associated with increased inflammatory placental pathology
Cárdenas, María C. , Cheek‐Norgan, E. Heidi, Norgan, Andrew P. , Schenone, Mauro , Lemens, Maureen A. , Chakraborty, Rana , Ruano, Rodrigo , Enninga, Elizabeth Ann L. , Branda, Megan E. , Ruano, Rodrigo , Enninga, Elizabeth Ann L , Norgan, Andrew P , Schenone, Mauro H

Mayo Clinic

Prenatal Diagnosis | January 23, 2023 | Volume: 43 | Issue: 3 | Pages: 382-392

10.1002/pd.6319 | PMID 36688485 Get It

AbstractObjectiveFetal surgery has improved neonatal outcomes; however, it is unknown if the intervention contributes to the developmental of inflammatory pathologies in the placenta. Here, an association between fetal surgery and placental pathology was examined.MethodThis case‐control study compared pregnancies with fetal surgery (n = 22), pregnancies with an indication for fetal surgery but without an intervention being done (n = 13), and gestational‐age and fetus‐number matched controls (n = 36). Data on maternal, infant, and placental outcomes were abstracted. Additionally, immunohistochemistry identified expression of lymphoid and myeloid cells in the placenta on a subset of cases. Comparisons were performed using Kruskal‐Wallis or Pearson's chi‐squared tests.ResultsMaternal characteristics were comparable between groups. Most fetal interventions were for diaphragmatic hernia, spina bifida, or twin‐to‐twin transfusion syndrome. Fetuses who were operated on before birth were more likely to be born preterm (p = 0.02). There was no increase in the rate of observed placental pathologies or immune cell infiltration in fetal surgery cases compared to controls.ConclusionThe data suggest that fetal surgery is not associated with increased inflammatory or morphologic pathology in the placenta. This observation supports the growing field of fetal surgery.